Atherosclerosis: Pathogenesis, Genetics and Experimental Models

Jonathon W Homeister, University of North Carolina, Chapel Hill, USA
Monte S Willis, University of North Carolina, Chapel Hill, USA

Published online: November 2010

DOI: 10.1002/9780470015902.a0005998.pub2

Atherosclerosis is a disease of the arteries that results in heart disease and stroke – the most common causes of death in developed countries, and a growing burden in developing countries. Atherosclerosis results from injury to the artery endothelium caused by mechanical and environmental factors, and the resulting inflammatory response in the vessel wall. The location and morphology of the atherosclerotic lesions predict the nature of the resulting vascular disease. Some risk factors for the disease are well known and current therapies are largely directed at modifying them, but the tendency to develop atherosclerosis is determined largely by polygenetic factors that are poorly understood. Recent developments in genetic studies have been applied to atherosclerosis, and are beginning to rapidly reveal the genetic factors that modulate the pathogenesis of this disease.

Key Concepts:

  • Atherosclerosis is a common, costly and deadly vascular disease that affects peoples of developed countries, and increasingly burdens developing countries.
  • Atherosclerosis is an inflammatory disease of the arterial vascular wall.
  • The pathogenesis of atherosclerosis is complex, but is generally explained by the ‘response to injury’ hypothesis.
  • Atherosclerotic lesions have varied morphology, and clinical manifestations correlate with lesion type and location.
  • Both environmental and heritable risk factors modulate atherosclerosis development.
  • Candidate gene and linkage analysis studies have failed to identify previously unknown pathways in the pathogenesis of atherosclerosis.
  • Recent publication of the HapMap has made possible genome-wide association studies aimed at probing the pathogenesis of atherosclerosis.
  • Recent genome-wide association studies have reproducibly identified several loci involved in the pathogenesis of atherosclerosis, and most of the identified genes are newly implicated in the disease process.
  • APOE- or LDLR-deficient mice are widely used models to study the pathogenesis of atherosclerosis.

Keywords: atheroma; atherosclerosis; coronary artery disease; endothelial dysfunction; foam cell; hyperlipidaemia; hypertension; myocardial infarct; stroke; vascular inflammation

Figure 1. Obstructive atherosclerotic disease in many vascular beds in a single individual. Angiography carried out in a 40-year-old male shows diffuse disease in the right (a) and left (b) coronary arteries, as well as focal lesions in the right iliac (c) and right renal arteries (d).
close
 References
    Andresdottir MB, Sigurdsson G, Sigvaldason H et al. (2002) Fifteen percent of myocardial infarctions and coronary revascularizations explained by family history unrelated to conventional risk factors. The Reykjavik Cohort Study. European Heart Journal 23: 1655–1663.
    Arking DE and Chakravarti A (2009) Understanding cardiovascular disease through the lens of genome-wide association studies. Trends in Genetics 25: 387–394.
    Broadbent HM, Peden JF, Lorkowski S et al. (2008) Susceptibility to coronary artery disease and diabetes is encoded by distinct, tightly linked SNPs in the ANRIL locus on chromosome 9p. Human Molecular Genetics 17: 806–814.
    Dansky HM, Shu P, Donavan M et al. (2002) A phenotype-sensitizing Apoe-deficient genetic background reveals novel atherosclerosis predisposition loci in the mouse. Genetics 160: 1599–1608.
    Erdmann J, Grosshennig A, Braund PS et al. (2009) New susceptibility locus for coronary artery disease on chromosome 3q22.3. Nature Genetics 41: 280–282.
    Folkersen L, Kyriakou T, Goel A et al. (2009) Relationship between CAD risk genotype in the chromosome 9p21 locus and gene expression. Identification of eight new ANRIL splice variants. PLoS ONE 4: e7677.
    Frazer KA, Ballinger DG, Cox DR et al. (2007) A second generation human haplotype map of over 3.1 million SNPs. Nature 449: 851–861.
    Frazer KA, Murray SS, Schork NJ et al. (2009) Human genetic variation and its contribution to complex traits. Nature Reviews. Genetics 10: 241–251.
    Hawe E, Talmud PJ, Miller GJ et al. (2003) Family history is a coronary heart disease risk factor in the Second Northwick Park Heart Study. Annals of Human Genetics 67: 97–106.
    Helgadottir A, Thorleifsson G, Magnusson KP et al. (2008) The same sequence variant on 9p21 associates with myocardial infarction, abdominal aortic aneurysm and intracranial aneurysm. Nature Genetics 40: 217–224.
    International HapMap Consortium (2005) A haplotype map of the human genome. Nature 437: 1299–1320.
    Ishibashi S, Goldstein JL, Brown MS et al. (1994) Massive xanthomatosis and atherosclerosis in cholesterol-fed low density lipoprotein receptor-negative mice. Journal of Clinical Investigation 93: 1885–1893.
    Kathiresan S, Voight BF, Purcell S et al. (2009) Genome-wide association of early onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nature Genetics 41: 334–341.
    Lander ES, Linton LM, Birren B et al. (2001) Initial sequencing and analysis of the human genome. Nature 409: 860–921.
    Lotta LA (2010) Genome-wide association studies in atherothrombosis. European Journal of Internal Medicine 21: 74–78.
    MacFarlane AJ, Perry CA, Girnary HH et al. (2009) Mthfd1 is an essential gene in mice and alters biomarkers of impaired one-carbon metabolism. Journal of Biological Chemistry 284: 1533–1539.
    Malarstig A and Hamsten A (2010) Genetics of atherothrombosis and thrombophilia. Current Atherosclerosis Reports 12: 159–166.
    McPherson R, Pertsemlidis A, Kavaslar N et al. (2007) A common allele on chromosome 9 associated with coronary heart disease. Science 316: 1488–1491.
    Morgan TM, Krumholz HM, Lifton RP et al. (2007) Nonvalidation of reported genetic risk factors for acute coronary syndrome in a large-scale replication study. JAMA 297: 1551–1561.
    Mosca L, Grundy SM, Judelson D et al. (1999) Guide to preventive cardiology for women AHA/ACC scientific statement consensus panel statement. Circulation 99: 2480–2484.
    Nielsen MS, Jacobsen C, Olivecrona G et al. (1999) Sortilin/neurotensin receptor-3 binds and mediates degradation of lipoprotein lipase. Journal of Biological Chemistry 274: 8832–8836.
    book NIH (2009) National Heart Lung and Blood Institute Fact Book. Bethesda, MN: National Institutes of Health.
    Nilsson SK, Christensen S, Raarup MK et al. (2008) Endocytosis of apolipoprotein A-V by members of the low density lipoprotein receptor and the VPS10p domain receptor families. Journal of Biological Chemistry 283: 25920–25927.
    O'Brien ER, Garvin MR, Dev R et al. (1994) Angiogenesis in human coronary atherosclerotic plaques. American Journal of Pathology 145: 883–894.
    Randak C, Roschinger W, Rolinski B et al. (2000) Three siblings with nonketotic hyperglycinaemia, mildly elevated plasma homocysteine concentrations and moderate methylmalonic aciduria. Journal of Inherited Metabolic Disease 23: 520–522.
    Redon R, Ishikawa S, Fitch KR et al. (2006) Global variation in copy number in the human genome. Nature 444: 444–454.
    Roberts R, Wells GA, Stewart AF et al. (2010) The genome-wide association study – a new era for common polygenic disorders. Journal of Cardiovascular Translational Research 3: 173–182.
    Ross R (1993) The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801–809.
    Ross R (1999) Atherosclerosis – an inflammatory disease. New England Journal of Medicine 340: 115–126.
    Samani NJ, Braund PS, Erdmann J et al. (2008) The novel genetic variant predisposing to coronary artery disease in the region of the PSRC1 and CELSR2 genes on chromosome 1 associates with serum cholesterol. Journal of Molecular Medicine 86: 1233–1241.
    Samani NJ, Erdmann J, Hall AS et al. (2007) Genome-wide association analysis of coronary artery disease. New England Journal of Medicine 357: 443–453.
    Schunkert H, Gotz A, Braund P et al. (2008) Repeated replication and a prospective meta-analysis of the association between chromosome 9p21.3 and coronary artery disease. Circulation 117: 1675–1684.
    Spence JD (2010) The role of lipoprotein(a) in the formation of arterial plaques, stenoses and occlusions. Canadian Journal of Cardiology 26(suppl A): 37A–40A.
    Stary HC, Chandler AB, Dinsmore RE et al. (1995) A definition of advanced types of atherosclerotic lesions and a histological classification of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arteriosclerosis, Thrombosis, and Vascular Biology 15: 1512–1531.
    Stary HC, Chandler AB, Glagov S et al. (1994) A definition of initial, fatty streak, and intermediate lesions of atherosclerosis. A report from the Committee on Vascular Lesions of the Council on Arteriosclerosis, American Heart Association. Arteriosclerosis and Thrombosis 14: 840–856.
    Teupser D, Tan M, Persky AD et al. (2006) Atherosclerosis quantitative trait loci are sex- and lineage-dependent in an intercross of C57BL/6 and FVB/N low-density lipoprotein receptor–/– mice. Proceedings of the National Academy of Sciences of the USA 103: 123–128.
    Teupser D, Wolfrum S, Tan M et al. (2009) Novel strategy using F1-congenic mice for validation of QTLs: studies at the proximal chromosome 10 atherosclerosis susceptibility locus. Arteriosclerosis, Thrombosis, and Vascular Biology 29: 678–683.
    Tregouet DA, Konig IR, Erdmann J et al. (2009) Genome-wide haplotype association study identifies the SLC22A3-LPAL2-LPA gene cluster as a risk locus for coronary artery disease. Nature Genetics 41: 283–285.
    Venter JC, Adams MD, Myers EW et al. (2001) The sequence of the human genome. Science 291: 1304–1351.
    Virmani R, Kolodgie FD, Burke AP et al. (2000) Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions. Arteriosclerosis, Thrombosis, and Vascular Biology 20: 1262–1275.
    Wang X, Ishimori N, Korstanje R et al. (2005) Identifying novel genes for atherosclerosis through mouse-human comparative genetics. American Journal of Human Genetics 77: 1–15.
    Wellcome Trust Case Control Consortium (2007) Genome-wide association study of 14 000 cases of seven common diseases and 3000 shared controls. Nature 447: 661–678.
    Wolfrum S, Rodriguez JM, Tan M et al. (2010) The mouse atherosclerosis locus at chromosome 10 (Ath11) acts early in lesion formation with subcongenic strains delineating 2 narrowed regions. Arteriosclerosis, Thrombosis, and Vascular Biology 30: 1583–1590.
    Yusuf S, Reddy S, Ounpuu S et al. (2001) Global burden of cardiovascular diseases: part I: general considerations, the epidemiologic transition, risk factors, and impact of urbanization. Circulation 104: 2746–2753.
    Zhang SH, Reddick RL, Piedrahita JA et al. (1992) Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258: 468–471.
 Further Reading
    Chen Y, Rollins J, Paigen B et al. (2007) Genetic and genomic insights into the molecular basis of atherosclerosis. Cell Metabolism 6: 164–179.
    book Libby P and Braunwald E (2008) Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine. Philadelphia: Saunders/Elsevier.
    Libby P, Ridker PM and Hansson GK (2009) Inflammation in atherosclerosis: from pathophysiology to practice. Journal of the American College of Cardiology 54: 2129–2138.
    Ramsey SA, Gold ES and Aderem A (2010) A systems biology approach to understanding atherosclerosis. EMBO Molecular Medicine 2: 79–89.
    Rocha VZ and Libby P (2009) Obesity, inflammation, and atherosclerosis. Nature Reviews. Cardiology 6: 399–409.
    Roy H, Bhardwaj S and Yla-Herttuala S (2009) Molecular genetics of atherosclerosis. Human Genetics 125: 467–491.
    Vickers KC and Remaley AT (2010) MicroRNAs in atherosclerosis and lipoprotein metabolism. Current Opinion in Endocrinology, Diabetes, and Obesity 17: 150–155.
    Weakley SM, Jiang J, Kougias P et al. (2010) Role of somatic mutations in vascular disease formation. Expert Review of Molecular Diagnostics 10: 173–185.

Related Sub-Topics:

Inflammation | Molecular Genetics of Common and Complex Disease | Model Organisms and Human Disease | Genetic Models | Lipids: Structure, Function, Metabolism
Contact Editor close
Submit a note to the editor about this article by filling in the form below.

* Required Field

Article Title: Atherosclerosis: Pathogenesis, Genetics and Experimental Models
 
How to Cite close
Homeister, Jonathon W, and Willis, Monte S(Nov 2010) Atherosclerosis: Pathogenesis, Genetics and Experimental Models. In: eLS. John Wiley & Sons Ltd, Chichester. http://www.els.net [doi: 10.1002/9780470015902.a0005998.pub2]